Hologic (HOLX) | Stock Overview & Key Data
Hologic Performance Comparison
Stock Range
Today's Range
Low: $67.67
High: $68.33
on August 8, 2025
52 Week Range
Low: $51.90
High: $84.67
on May 6, 2025
on August 9, 2024
All-Time High: $87.88 on May 1, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$14.9B
EPS
2.41
P/E Ratio (TTM)
27.76
Forward P/E
14.17
P/B Ratio
3.07
PEG Ratio
14.17
Div. Yield
N/A
ROE
11.38%
Beta
0.490
Debt to Equity
52.09
Financial Highlights
Profitability
Gross Margin
56.32%
Operating Margin
25.48%
Profit Margin
13.79%
Returns and Earnings
Return on Assets (TTM)
6.69%
Return on Equity (TTM)
11.38%
EBITDA
$1.1B
Net Income (TTM)
$557.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$17.43
Quarterly Revenue Growth (YoY)
1.20%
Quarterly Earnings Growth (YoY)
0.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Hologic HOLX | 14.88B Large-cap | 1.34% | 4.87% | 21.15% | 4.32% | -5.13% | -18.63% | -6.75% | 1.87% |
| Intuitive Surgical ISRG | 169.94B Large-cap | -2.70% | -10.85% | -12.65% | -21.09% | -10.30% | 1.43% | 97.21% | 106.02% |
| Becton, Dickinson BDX | 53.31B Large-cap | 9.71% | 10.81% | 15.21% | -15.70% | -14.57% | -17.97% | -26.61% | -23.17% |
| Alcon ALC | 45.84B Large-cap | -2.41% | -1.49% | -10.57% | -3.95% | 2.76% | -7.73% | 22.36% | 39.35% |
| ResMed RMD | 41.63B Large-cap | 1.68% | 10.64% | 16.79% | 19.01% | 24.26% | 31.08% | 18.30% | 60.60% |
| West Pharmaceutical WST | 17.34B Large-cap | 0.72% | 9.30% | 12.22% | -25.65% | -26.62% | -16.28% | -29.33% | -11.56% |
Ownership & Short Interest
Insider Ownership
0.86%
Institutional Ownership
104.29%
Shares Short
5M
Short Ratio
2.16
Short % of Shares Outstanding
3.06%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Hologic Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Hologic would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HOLX's 52-week high and low?
- In the last 52 weeks, Hologic reached a high of $84.67 (on August 9, 2024) and a low of $51.90 (on May 6, 2025).
- What is the market cap and P/E ratio for HOLX?
- Curious about Hologic's size and valuation? Its market capitalization stands at 14.88B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.76, and the forward P/E (looking ahead) is 14.17.
- Does HOLX pay dividends? If so, what's the yield?
- As for dividends, Hologic isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Hologic's main competitors or similar companies to consider before investing?
When looking at Hologic, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG169.94B Healthcare Medical Instruments & Supplies 1.43% 97.21% Becton, Dickinson
BDX53.31B Healthcare Medical Instruments & Supplies -17.97% -26.61% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -7.73% 22.36% ResMed
RMD41.63B Healthcare Medical Instruments & Supplies 31.08% 18.30% West Pharmaceutical
WST17.34B Healthcare Medical Instruments & Supplies -16.28% -29.33% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Hologic Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Hologic's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.38%, the Debt to Equity ratio from the most recent quarter is 52.09, and its Gross Profit Margin stands at 56.32%.
- What is the recent revenue and earnings growth for HOLX?
- Looking at Hologic's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1.20%, and quarterly earnings saw a YoY growth of 0.20%.
- How much of HOLX stock is held by insiders and institutions?
- Wondering who owns Hologic stock? Company insiders (like executives and directors) hold about 0.86% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 104.29%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.